Sucroferric Oxyhydroxide
Sucroferric oxyhydroxide is an iron-based phosphate binder used to manage hyperphosphatemia in adult patients with chronic kidney disease on hemodialysis or peritoneal dialysis. When taken with meals, it binds to dietary phosphate in the gastrointestinal tract, preventing its absorption and reducing phosphorus levels in the blood.
Dosage by Body Weight
The recommended starting dose is 1,500 mg (3 tablets) per day, divided as 1 tablet (500 mg) taken three times daily with meals. Dosage should be adjusted based on serum phosphorus levels, typically weekly in increments of 500 mg per day. Tablets must be chewed or crushed before swallowing; do not swallow them whole.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients have not been established. |
Formulation
Purpose
Control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Generic Name
Sucroferric OxyhydroxideBranded Drug Names
Sucroferric Oxyhydroxide is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.